Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$164.00M
Total Bought:
$39.11M
Total Sold:
$38.70M
Net Transaction:
+$409.8K
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and CompanyCOM(LLY)20,77827,144+6,366$16.16M$24.58M14.98%+$8.41M
UnitedHealth Group IncorporatedCOM(UNH)23,04131,680+8,639$11.40M$16.13M9.84%+$4.73M
Merck & Co., Inc.COM(MRK)133,741112,734-21,007$17.65M$13.96M8.51%-$3.69M
Thermo Fisher Scientific Inc.COM(TMO)15,18619,458+4,272$8.83M$10.76M6.56%+$1.93M
Amgen Inc.COM(AMGN)18,89127,589+8,698$5.37M$8.62M5.26%+$3.25M
Boston Scientific CorporationCOM(BSX)77,401106,557+29,156$5.30M$8.21M5.00%+$2.90M
Regeneron Pharmaceuticals, Inc.COM(REGN)5,3936,893+1,500$5.19M$7.24M4.42%+$2.05M
Vertex Pharmaceuticals IncorporatedCOM(VRTX)11,29515,095+3,800$4.72M$7.08M4.31%+$2.35M
CENCORA INCCOM20,42630,320+9,894$4.96M$6.83M4.17%+$1.87M
Stryker CorporationCOM(SYK)15,15419,983+4,829$5.42M$6.80M4.15%+$1.38M
AbbVie Inc.COM(ABBV)29,34635,618+6,272$5.34M$6.11M3.73%+$765.3K
DexCom, Inc.COM(DXCM)26,28334,483+8,200$3.65M$3.91M2.38%+$264.2K
EDWARDS LIFESCIENCES CORPCOM24,77536,505+11,730$2.37M$3.37M2.06%+$1.00M
Neurocrine Biosciences, Inc.COM(NBIX)43,48023,630-19,850$6.00M$3.25M1.98%-$2.74M
IQVIA Holdings Inc.COM(IQV)10,05813,984+3,926$2.54M$2.96M1.80%+$413.2K
Molina Healthcare, Inc.COM(MOH)12,0009,500-2,500$4.93M$2.82M1.72%-$2.11M
Cardinal Health, Inc.COM(CAH)27,50027,5000$3.08M$2.70M1.65%-$373.4K
UFP Technologies, Inc.COM(UFPT)09,800+9,800$0$2.59M1.58%+$2.59M
Mirum Pharmaceuticals, Inc.COM(MIRM)123,00075,200-47,800$3.09M$2.57M1.57%-$518.7K
INTRA-CELLULAR THERAPIES INCCOM38,05035,841-2,209$2.63M$2.45M1.50%-$178.3K
Ionis Pharmaceuticals, Inc.COM(IONS)63,79140,691-23,100$2.77M$1.94M1.18%-$826.0K
MERUS N VCOM24,32530,837+6,512$1.10M$1.82M1.11%+$729.3K
Corbus Pharmaceuticals Holdings, Inc.COM NEW(CRBP)38,00039,100+1,100$1.49M$1.77M1.08%+$278.2K
Alkermes plcSHS(ALKS)068,800+68,800$0$1.66M1.01%+$1.66M
Option Care Health, Inc.COM NEW(OPCH)132,89554,395-78,500$4.46M$1.51M0.92%-$2.95M
AMICUS THERAPEUTICS INCCOM
COM
252,307148,207-104,100$2.97M$1.47M0.90%-$1.50M
NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES
ORDINARY SHARES
22,39475,794+53,400$529.6K$1.46M0.89%+$926.4K
Krystal Biotech, Inc.COM(KRYS)6,6247,624+1,000$1.18M$1.40M0.85%+$221.5K
BridgeBio Pharma, Inc.COM(BBIO)37,84153,432+15,591$1.17M$1.35M0.83%+$183.4K
ARCELLX INCCOMMON STOCK
COMMON STOCK
17,49622,496+5,000$1.22M$1.24M0.76%+$24.7K
Harmony Biosciences Holdings, Inc.COM(HRMY)170,00034,900-135,100$5.71M$1.05M0.64%-$4.66M
Immunocore Holdings plcADS(IMCR)40,89923,778-17,121$2.66M$805.8K0.49%-$1.85M
Autolus Therapeutics plcSPON ADS(AUTL)96,345226,145+129,800$614.7K$787.0K0.48%+$172.3K
MORPHIC HLDG INCCOM14,95220,199+5,247$526.3K$688.2K0.42%+$161.9K
PHARVARIS N VCOM
COM
034,328+34,328$0$645.4K0.39%+$645.4K
MacroGenics, Inc.COM(MGNX)49,307143,407+94,100$725.8K$609.5K0.37%-$116.3K
Cabaletta Bio, Inc.COM(CABA)77,54064,321-13,219$1.32M$481.1K0.29%-$841.7K
MERSANA THERAPEUTICS INCCOM100,000184,900+84,900$448.0K$371.6K0.23%-$76.4K
Akero Therapeutics Inc24,4320-24,432$617.2K$0—-$617.2K
Cytokinetics, Incorporated(CYTK)14,0000-14,000$981.5K$0—-$981.5K
Elevance Health, Inc.(ELV)7,4000-7,400$3.84M$0—-$3.84M
Endeavour Silver Corp.(EXK)16,1200-16,120$1.11M$0—-$1.11M
Fusion Pharmaceuticals Inc138,8360-138,836$2.96M$0—-$2.96M
Gilead Sciences, Inc.(GILD)52,0000-52,000$3.81M$0—-$3.81M
Inspire Medical Systems, Inc.(INSP)4,7820-4,782$1.03M$0—-$1.03M
Madrigal Pharmaceuticals, Inc.(MDGL)3,5390-3,539$945.1K$0—-$945.1K
Shockwave Med Inc4,7510-4,751$1.55M$0—-$1.55M
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q2 2024 | TickerTrail